[Reduction of coronary risk factors with selective alpha-blockers. International Doxazosin Symposium. Frankfurt/Main, 7 June 1986].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D017292:Doxazosin; D006801:Humans; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012306:Risk
D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin; D011224:Prazosin
Senkung des koronaren Risikos mit selektiven Alpha-Blockern. Internationales Doxazosin-Symposium, Frankfurt/M. 1986.